These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 38275971)

  • 21. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19.
    Manik M; Singh RK
    J Med Virol; 2022 Mar; 94(3):869-877. PubMed ID: 34672376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles.
    Gamage AM; Tan KS; Chan WOY; Liu J; Tan CW; Ong YK; Thong M; Andiappan AK; Anderson DE; Wang Y; Wang LF
    PLoS Pathog; 2020 Dec; 16(12):e1009130. PubMed ID: 33284849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjugation with 8-arm PEG and CRM
    Tang X; Yu W; Shen L; Qi J; Hu T
    Int Immunopharmacol; 2022 Aug; 109():108922. PubMed ID: 35687905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
    Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
    Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique view of SARS-CoV-2 through the lens of ORF8 protein.
    Hassan SS; Aljabali AAA; Panda PK; Ghosh S; Attrish D; Choudhury PP; Seyran M; Pizzol D; Adadi P; Abd El-Aziz TM; Soares A; Kandimalla R; Lundstrom K; Lal A; Azad GK; Uversky VN; Sherchan SP; Baetas-da-Cruz W; Uhal BD; Rezaei N; Chauhan G; Barh D; Redwan EM; Dayhoff GW; Bazan NG; Serrano-Aroca Á; El-Demerdash A; Mishra YK; Palu G; Takayama K; Brufsky AM; Tambuwala MM
    Comput Biol Med; 2021 Jun; 133():104380. PubMed ID: 33872970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 ORF8 accessory protein is a virulence factor.
    Bello-Perez M; Hurtado-Tamayo J; Mykytyn AZ; Lamers MM; Requena-Platek R; Schipper D; Muñoz-Santos D; Ripoll-Gómez J; Esteban A; Sánchez-Cordón PJ; Enjuanes L; Haagmans BL; Sola I
    mBio; 2023 Oct; 14(5):e0045123. PubMed ID: 37623322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.
    Hassan SS; Kodakandla V; Redwan EM; Lundstrom K; Pal Choudhury P; Abd El-Aziz TM; Takayama K; Kandimalla R; Lal A; Serrano-Aroca Á; Azad GK; Aljabali AAA; Palù G; Chauhan G; Adadi P; Tambuwala M; Brufsky AM; Baetas-da-Cruz W; Barh D; Azevedo V; Bazan NG; Andrade BS; Santana Silva RJ; Uversky VN
    PeerJ; 2022; 10():e13136. PubMed ID: 35341060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells.
    Kim IJ; Lee YH; Khalid MM; Chen IP; Zhang Y; Ott M; Verdin E
    J Biol Chem; 2023 Aug; 299(8):104955. PubMed ID: 37354973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein.
    Fernandes MF; Chan JZ; Hung CCJ; Tomczewski MV; Duncan RE
    Life Sci; 2022 Jul; 301():120624. PubMed ID: 35568225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion.
    Neches RY; Kyrpides NC; Ouzounis CA
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational suppression of SARS-COV-2 ORF8 protein mRNA as a Viable therapeutic target against COVID-19: Computational studies on potential roles of isolated compounds from Clerodendrum volubile leaves.
    Erukainure OL; Atolani O; Muhammad A; Ravichandran R; Abarshi MM; Katsayal SB; Chukwuma CI; Preissner R; Banerjee P; Mesaik MA
    Comput Biol Med; 2021 Dec; 139():104964. PubMed ID: 34688170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
    Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
    J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective ORF8 dimerization in SARS-CoV-2 delta variant leads to a better adaptive immune response due to abrogation of ORF8-MHC1 interaction.
    Chaudhari AM; Singh I; Joshi M; Patel A; Joshi C
    Mol Divers; 2023 Feb; 27(1):45-57. PubMed ID: 35243596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway.
    Lin X; Fu B; Yin S; Li Z; Liu H; Zhang H; Xing N; Wang Y; Xue W; Xiong Y; Zhang S; Zhao Q; Xu S; Zhang J; Wang P; Nian W; Wang X; Wu H
    iScience; 2021 Apr; 24(4):102293. PubMed ID: 33723527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer.
    Matsuoka K; Imahashi N; Ohno M; Ode H; Nakata Y; Kubota M; Sugimoto A; Imahashi M; Yokomaku Y; Iwatani Y
    J Biol Chem; 2022 Mar; 298(3):101724. PubMed ID: 35157849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity.
    Beaudoin-Bussières G; Arduini A; Bourassa C; Medjahed H; Gendron-Lepage G; Richard J; Pan Q; Wang Z; Liang C; Finzi A
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.